17 January 2018
News and Views
Links and Services
The latest Alimentary Pharmacology & Therapeutics investigated second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed.
One-third of patients with Crohn's disease or ulcerative colitis receiving anti-TNFs do not respo
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors